Somalis have a unique pharmacological profile. We're an understudied population, too.
I posted that specific study around when it came out (I think another guy did the same time), and focused more on the diabetes susceptibility.
It's a mix of medical and ancestry related stuff published in Nature. The article stated that we had some genes associated with Diabetes type 1 at a very high frequency. They referenced another study from Finland that claimed Horn Africans had higher susceptibility than the Europeans, with the...
www.somalispot.com
Somalis really don't have Natufian-derived ancestry, and the autoimmune architecture in populations can shift through internal selection, drift, and whatnot. It is not 1:1. We're neither Natufian nor Nilotic, and we've had a stable Cushitic ancestry signature for ~8000 years. That is ample time to develop unique adaptation directions that make us respond differently to specific environmental pressures.
For example, we have only 23-24% of lactase persistence genetics that are mapped, but over 75% can consume milk. There are a lot of things we don't understand. Dinkas have high consumption yet have 0%. Take the Nubians. They have much lower milk consumption -- similar to Europeans-- their lactase persistence frequency matches the milk consumption, where experience of malabsorption arises for those that lack these LP alleles.
For intermediate populations, you can see phenotype expressions that can fluctuate widely between two hypothetical poles, with several unique pathways also adding to the dimensions. Certain traits of Somalis in the genetic diversity could be entirely African or Eurasian. There has to be genomic research. Ashkenazi Jews have a unique response to things as well, and they are punching above their demographic weight in their public health concerns, being relatively overrepresented.